EPHX2 and COVID-19: However, if inhibitors of the sEH are administered, the edema from EpOMEs is blocked but not that from the DiHOMEs (Moghaddam et al., 1997), suggesting that DiHOMEs play a role in lung disease and possibly a role in the pathophysiology of COVID-19.